Optieskoper schreef op 7 februari 2020 15:52:
[...]
A British-listed biotech company has applied for emergency approval from US regulators to fast-track clearance of a test for the coronavirus.
Novacyt Group, which is also listed in Paris and specialises in clinical diagnostics, said that demand for its test had soared since the outbreak of the disease in China. It said it had received orders for 33,000 tests and requests for quotations for another 32,000 from more than 30 countries.
Emergency approval from the Food and Drug Administration would allow
Daarna vervaagt het